Trial Outcomes & Findings for Gait Modifications and Cutaneous Stimulation (NCT NCT02884414)
NCT ID: NCT02884414
Last Updated: 2021-01-08
Results Overview
Within-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
56 participants
Primary outcome timeframe
Immediate
Results posted on
2021-01-08
Participant Flow
Participant milestones
| Measure |
Cutaneous Stimulation
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external.
Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
|
|---|---|
|
Overall Study
STARTED
|
56
|
|
Overall Study
COMPLETED
|
56
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Data excluded from n=3 participants due to technical data collection issue.
Baseline characteristics by cohort
| Measure |
Cutaneous Stimulation
n=56 Participants
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external.
Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
|
|---|---|
|
Age, Continuous
|
47.8 years
STANDARD_DEVIATION 18.5 • n=56 Participants
|
|
Sex: Female, Male
Female
|
26 Participants
n=56 Participants
|
|
Sex: Female, Male
Male
|
30 Participants
n=56 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Asian
|
17 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=56 Participants
|
|
Race (NIH/OMB)
White
|
36 Participants
n=56 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=56 Participants
|
|
Region of Enrollment
United States
|
56 participants
n=56 Participants
|
|
Knee Flexion Moment
|
2.68 %Bw*Ht
STANDARD_DEVIATION 1.29 • n=53 Participants • Data excluded from n=3 participants due to technical data collection issue.
|
PRIMARY outcome
Timeframe: ImmediateWithin-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).
Outcome measures
| Measure |
Cutaneous Stimulation
n=53 Participants
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external.
Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
|
|---|---|
|
Change in Peak Knee Flexion Moment (%Bw*Ht)
|
2.72 %Bw*Ht
Standard Deviation 1.25
|
Adverse Events
Cutaneous Stimulation
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place